Skip to Content

PRIMECAP Odyssey Stock POSKX

Medalist Rating as of | See PRIMECAP Investment Hub
  • NAV / 1-Day Return 40.13  /  −1.50 %
  • Total Assets 5.7 Bil
  • Adj. Expense Ratio
    0.670%
  • Expense Ratio 0.670%
  • Distribution Fee Level Below Average
  • Share Class Type No Load
  • Category Large Blend
  • Investment Style Large Blend
  • Min. Initial Investment 2,000
  • Status Open
  • TTM Yield 1.00%
  • Turnover 4%

USD | NAV as of Jul 17, 2024 | 1-Day Return as of Jul 17, 2024, 10:16 PM GMT+0

Morningstar’s Analysis POSKX

Will POSKX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

Still strong after a middling half-decade.

Strategist Robby Greengold

Robby Greengold

Strategist

Summary

We have qualitatively reviewed this strategy and reaffirmed its Process and People ratings. Primecap Odyssey Stock stands out for its seasoned management and high-conviction multimanager system. The remainder of this analysis is from July 7, 2023.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings POSKX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 37.4
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Eli Lilly and Co

10.37 624.4 Mil
Healthcare

AstraZeneca PLC ADR

3.66 220.3 Mil
Healthcare

Dreyfus Treasury Secs Cash Mgmt Inst

3.61 217.3 Mil
Corporate

AECOM

3.35 201.5 Mil
Industrials

KLA Corp

3.31 199.4 Mil
Technology

Microsoft Corp

3.07 184.7 Mil
Technology

Intel Corp

3.02 182.2 Mil
Technology

FedEx Corp

2.84 171.2 Mil
Industrials

Siemens AG

2.68 161.2 Mil
Industrials

Amgen Inc

2.59 155.7 Mil
Healthcare